Corporate Banner
Satellite Banner
Chromatography
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Malvern Discussion of Analytical Toolkit for Biopharmaceutical Applications is Now Available Online

Published: Friday, April 12, 2013
Last Updated: Friday, April 12, 2013
Bookmark and Share
View online at http://bit.ly/MALOTACB.

A recent Malvern Instruments sponsored webinar, presented by specialists from the company, examined the need for specific analytical tools for biopharmaceutical applications.

The recording of the live event, which attracted more than 600 registrants, is now available to view online at http://bit.ly/MALOTACB.

In the presentation, Mark Pothecary and Paul Clarke, Product Manager and Product Group Manager respectively for Nanoparticle and Molecular Characterization at Malvern Instruments, discuss a variety of the analytical technologies that are available for the growing biopharmaceutical industry.

They provide fresh insights into the use of a number of well-established characterization techniques, including light scattering and size exclusion chromatography (GPC/SEC) and illustrate the use of these techniques in combination, showing how they can provide a wide range of complementary information useful to protein scientists.

The continued shift within the industry towards biopharmaceuticals has resulted in the need for analytical instrumentation that can quickly deliver compelling solutions to meet rapidly evolving analytical and regulatory challenges.

In particular the move towards drugs using biomolecules as the active has stimulated advances in new analytical procedures. As well as traditional techniques, such as GPC/SEC and dynamic light scattering (DLS), which can be performed separately or in combination (SEC-DLS), new technologies including microrheology and resonant mass measurement are rapidly becoming essential components of the analytical toolkit.

Within Malvern Instruments, the company’s global Bioscience Development Initiative recognizes the unprecedented pace of development in biopharmaceuticals and the onus this places on analytical instrumentation companies to quickly deliver solutions to a host of rapidly evolving analytical and regulatory challenges.

Malvern’s Bioscience Development Initiative is focused specifically on the requirements of the biopharmaceutical sector, most notably the biochemical and biophysical characterization needs relating to formulation and product development.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Malvern Instruments Opens New Multipurpose Facility in Houston
At 22,000 sq. ft. the new building is double the size of Malvern’s previous premises in Houston and houses state-of-the-art laboratories, product development, manufacturing and commercial operations.
Tuesday, March 27, 2012
Malvern Instruments and Postnova Analytics Co-operate
Both companies co-operate to deliver combined solution for characterizing challenging particulate systems.
Friday, February 17, 2012
Malvern Scientists will lead Protein Characterization Workshop at PEGS Summit
Drs Kevin Mattison, Ulf Nobbmann and Jason Sanchez will lead a workshop at the 7th Annual PEGS.
Tuesday, September 13, 2011
Malvern Instruments and Purdue University Present Joint Symposium on Light Scattering Techniques for Nanoparticle Characterization
The symposium will take place on the Purdue Campus at West Lafayette, Indiana.
Thursday, September 08, 2011
Scientific News
Portable Kit Can Recover Traces of Chemical Evidence
A chemist at the National Institute of Standards and Technology (NIST) has developed a portable version of his method for recovering trace chemicals such as environmental pollutants and forensic evidence including secret graves and arson fire debris.
Diagnosis of Two Rare Childhood Diseases Improved
For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs.
Artemisinin Mechanism Uncovered
New understanding of how artemisinin works could facilitate development of new drugs and therapeutic strategies against malaria.
Cleaning Out the Membrane Each Day
Cell membranes are made up of a lipid bilayer that is constantly changing due to the flux of material in and out of the cell.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Novel Approach to Understanding Brain Function
Russell Poldrack scanned his brain to create the most detailed map of brain connectivity ever.
New Analysis Technique for Chiral Activity in Molecules
Professor Hyunwoo Kim of the Chemistry Department and his research team have developed a technique that can easily analyze the optical activity of charged compounds by using nuclear magnetic resonance (NMR) spectroscopy.
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!